Skip to main content

Vanderbilt Vaccine Center Archives

VU researchers ‘goldsmith’ new RSV vaccine approach

Jul. 18, 2013—Vanderbilt vaccine researchers are using gold nanotechnology to develop a new approach to making vaccines.

Read more


Grant targets new therapies for Ebola, Marburg viruses

May. 16, 2013—Vanderbilt’s James Crowe Jr., M.D., and a collaborator in Texas have been awarded a $4.4 million grant from the U.S. Department of Defense to study new ways to treat and prevent Ebola and Marburg viruses.

Read more


Structural snapshot hints at new influenza approach

Feb. 21, 2013—A careful look at how the body’s natural defenses disarm virulent strains of influenza hints at the possibility of a way to fight the flu.

Read more


Repository samples help shape view of new rhinovirus

Dec. 6, 2012—Vanderbilt researchers used a treasure trove of samples collected and stored at the Vanderbilt Vaccine Clinic (VVC) to prove a particular human rhinovirus (HRV), has been causing more than just the common cold for decades.

Read more


VUMC researchers reveal darker side of common cold

Jan. 5, 2012—Human rhinovirus (HRV), also known as the common cold, can be uncommonly serious for certain children, a study led by a Vanderbilt University Medical Center pediatrician shows. The study, published in the Dec. 28, 2011 online issue of the journal Pediatrics, shows that not only can HRV lead to hospitalization in very low birth weight...

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more